Sino Biopharmaceutical Limited/ADR (SBMFF) research
Sino Biopharmaceutical Limited/ADR- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.69
- As of
Sino Biopharmaceutical Limited/ADR (SBMFF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and no SEC filing for the company is on record.
As of . Source: SEC EDGAR filings for SBMFF. Method and limitations.
Share the SBMFF intelligence card
See the full SBMFF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SBMFF on one page. Preview it with sample data, then open it live with a free account.
Preview the SBMFF dossierActive signals for SBMFF
- mediumEARNINGS_MISS
Q3-2020: Missed consensus by 41.2% - EPS $0.03 vs $0.051 estimate
- mediumEARNINGS_MISS
Missed consensus by 41.2% - EPS $0.03 vs $0.051 estimate
- mediumEARNINGS_BEAT
Q1-2021: Beat consensus by 85.4% - EPS $0.104 vs $0.0561 estimate
- mediumEARNINGS_BEAT
Q2-2021: Beat consensus by 208.1% - EPS $0.33 vs $0.1071 estimate
FREE, NO ACCOUNT
Every signal on SBMFF, as it fires
New filings, 13F moves and cross asset signals on SBMFF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Related tickers
See more SBMFF signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SBMFFand get the insider, 13F, options, and confluence read in one view.